Prime has been a leader on controlled substances misuse for more than a decade. Our program combines existing and new services to help address this national epidemic.

New model reduces risk

Opioid misuse and over-prescription continues to be a major issue in the U.S. Our experience taught us that a multi-pronged model is the most effective way to fight this epidemic.

In addition to our current controlled substance efforts, we created a controlled substance management program. One of the highlights is a controlled substance score. It identifies people at risk of controlled substance misuse through predictive modeling.

The score is calculated by evaluating the:

• Number of unique controlled substance claims
• Total unique pharmacies and prescribers
• Utilization rate over time

This score then is used with our GuidedHealth^® rules engine, which identifies drug therapy opportunities and encourages doctors to target and prioritize interventions.

More about our controlled substance score

Prime Therapeutics applauds cross-functional opioid epidemic report from Clinton Foundation and Johns Hopkins Bloomberg School of Public Health

New public opinion survey finds few safely dispose of unused medicine, most opioid users weren’t told about the potential for opioid addiction

Prime Therapeutics’ Dr. Gleason discusses opioid epidemic on Minnesota Public Radio

Disposing of unused medicines the right way: A how-to

5-part series - America’s opioid epidemic: An emergency

Prime Therapeutics controlled substance management program helped decrease opioid use among those at highest risk

AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics join Walgreens to combat prescription drug abuse by expanding safe medication disposal program

3 real actions Prime is taking against the opioid crisis